Articles

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function

Anthony Nolan Research Institute, London;
Department of Haematology, Imperial College London;
Cellular Therapeutics, University College London;
Department of Hematology, Royal Free London NHS Trust, London;
Department of Hematology, Royal Free London NHS Trust, London;
Department of Hematology, University College Hospital NHS Trust, London;
Department of Hematology, University College Hospital NHS Trust, London;
Cellular Therapeutics, University College London;
Anthony Nolan Research Institute, London;
Anthony Nolan Research Institute, London;
Department of Hematology, University College Hospital NHS Trust, London;
Department of Hematology, University College Hospital NHS Trust, London;
Department of Hematology, University College Hospital NHS Trust, London;
Department of Hematology, University College Hospital NHS Trust, London;
Department of Hematology, University College Hospital NHS Trust; Cancer Institute UCL, London
Department of Hematology, University College Hospital NHS Trust, London;
Department of Hematology, University College Hospital NHS Trust; Cancer Institute UCL, London
Department of Hematology, University College Hospital NHS Trust; Cancer Institute UCL, London
Haematologica Early view Nov 21, 2019 https://doi.org/10.3324/haematol.2019.226340